Healthcare provider profile · identity verified

Timothy D Drews, MD

Family Practice · MOUNT HOREB, WI · NPI 1336118868

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	373	96
Amlodipine Besylate	Amlodipine Besylate	263	69
Omeprazole	Omeprazole	205	42
Levothyroxine Sodium	Levothyroxine Sodium	201	52
Rosuvastatin Calcium	Rosuvastatin Calcium	195	55
Losartan Potassium	Losartan Potassium	167	52
Metoprolol Succinate	Metoprolol Succinate	155	31
Lisinopril	Lisinopril	148	41
Eliquis	Apixaban	134	26
Pantoprazole Sodium	Pantoprazole Sodium	113	28
Hydrochlorothiazide	Hydrochlorothiazide	93	33
Tamsulosin Hcl	Tamsulosin Hcl	91	31
Metformin Hcl Er	Metformin Hcl	86	30
Simvastatin	Simvastatin	81	23
Sertraline Hcl	Sertraline Hcl	78	15
Furosemide	Furosemide	74	20
Potassium Chloride	Potassium Chloride	73	18
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	71	12
Metoprolol Tartrate	Metoprolol Tartrate	67	20
Gabapentin	Gabapentin	66	21
Trazodone Hcl	Trazodone Hcl	64	14
Famotidine	Famotidine	61	18
Pregabalin	Pregabalin	56	12
Alendronate Sodium	Alendronate Sodium	54	17
Duloxetine Hcl	Duloxetine Hcl	53	17
Lorazepam	Lorazepam	51	12
Chlorthalidone	Chlorthalidone	50	15
Mirtazapine	Mirtazapine	50	suppressed
Morphine Sulfate Er	Morphine Sulfate	50	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	44	suppressed
Oxycodone Hcl	Oxycodone Hcl	43	suppressed
Trulicity	Dulaglutide	42	suppressed
Clopidogrel	Clopidogrel Bisulfate	40	12
Metformin Hcl	Metformin Hcl	40	suppressed
Fluticasone Propionate	Fluticasone Propionate	38	16
Pravastatin Sodium	Pravastatin Sodium	38	12
Carvedilol	Carvedilol	37	12
Warfarin Sodium	Warfarin Sodium	37	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	35	16
Allopurinol	Allopurinol	35	suppressed
Clonazepam	Clonazepam	35	suppressed
Ozempic	Semaglutide	35	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	33	19
Buspirone Hcl	Buspirone Hcl	31	suppressed
Meloxicam	Meloxicam	30	11
Mounjaro	Tirzepatide	30	suppressed
Alprazolam	Alprazolam	29	suppressed
Citalopram Hbr	Citalopram Hydrobromide	29	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	27	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	26	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	25	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	25	suppressed
Spironolactone	Spironolactone	24	suppressed
Atenolol	Atenolol	23	suppressed
Donepezil Hcl	Donepezil Hcl	23	suppressed
Prednisone	Prednisone	23	suppressed
Diclofenac Sodium	Diclofenac Sodium	22	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	21	suppressed
Benazepril Hcl	Benazepril Hcl	21	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	21	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	21	suppressed
Levetiracetam	Levetiracetam	21	suppressed
Digoxin	Digoxin	20	suppressed
Glipizide	Glipizide	19	suppressed
Lamotrigine	Lamotrigine	19	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	19	suppressed
Xarelto	Rivaroxaban	19	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	18	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	18	suppressed
Glipizide Er	Glipizide	18	suppressed
Nifedipine Er	Nifedipine	18	suppressed
Bupropion Xl	Bupropion Hcl	17	suppressed
Clobetasol Propionate	Clobetasol Propionate	17	suppressed
Ezetimibe	Ezetimibe	17	suppressed
Indapamide	Indapamide	17	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	17	14
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	16	suppressed
Memantine Hcl	Memantine Hcl	16	suppressed
Varenicline Tartrate	Varenicline Tartrate	16	suppressed
Vascepa	Icosapent Ethyl	16	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	15	suppressed
Jardiance	Empagliflozin	15	suppressed
Myrbetriq	Mirabegron	15	suppressed
Prochlorperazine Maleate	Prochlorperazine Maleate	15	suppressed
Propranolol Hcl	Propranolol Hcl	15	suppressed
Enalapril Maleate	Enalapril Maleate	14	suppressed
Lovastatin	Lovastatin	14	suppressed
Ondansetron Hcl	Ondansetron Hcl	14	suppressed
Oxcarbazepine	Oxcarbazepine	14	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	14	suppressed
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	13	suppressed
Divalproex Sodium Er	Divalproex Sodium	13	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	13	suppressed
Farxiga	Dapagliflozin Propanediol	13	suppressed
Ibuprofen	Ibuprofen	13	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	13	suppressed
Methadone Hcl	Methadone Hcl	13	suppressed
Oxycontin	Oxycodone Hcl	13	suppressed
Tizanidine Hcl	Tizanidine Hcl	13	suppressed
Topiramate	Topiramate	13	suppressed
Volnea	Desog-E.Estradiol/E.Estradiol	13	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	12	suppressed
Amoxicillin	Amoxicillin	12	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	12	suppressed
Estradiol	Estradiol	12	suppressed
Lubiprostone	Lubiprostone	12	suppressed
Mexiletine Hcl	Mexiletine Hcl	12	suppressed
Montelukast Sodium	Montelukast Sodium	12	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	12	suppressed
Hydralazine Hcl	Hydralazine Hcl	11	suppressed
Loperamide	Loperamide Hcl	11	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	11	suppressed
Ondansetron Odt	Ondansetron	11	suppressed
Tramadol Hcl	Tramadol Hcl	11	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error